Summary

Market Overview
The Global Virology Specimen Collection Market was valued at USD 6.50 billion in 2024 and is projected to reach USD 8.47 billion by 2030, growing at a CAGR of 4.51% during the forecast period. The market is being propelled by advancements in specimen collection technologies such as immunoassays, nucleic acid amplification techniques, PCR methods, mass spectrometry, and next-generation sequencing (NGS), all aimed at delivering fast and accurate diagnostics for various viral infections. In addition, increasing investment in research and development within the pharmaceutical and biopharmaceutical sectors is further driving demand. The growing focus on large molecule drug development in biopharmaceuticals is also contributing to the market’s expansion over the coming years.
Key Market Drivers
Rising Global Burden of Viral Infections
The growing prevalence and recurrence of viral infections worldwide are key factors accelerating the virology specimen collection market. Conditions such as HIV, hepatitis, influenza, respiratory syncytial virus (RSV), and the recent emergence of COVID-19 necessitate reliable diagnostic practices that begin with high-quality specimen collection. According to the World Health Organization (WHO), seasonal influenza alone causes between 290,000 and 650,000 respiratory deaths annually. Additionally, WHO’s 2023 hepatitis report revealed that 254 million people are living with chronic hepatitis B and 50 million with hepatitis C. These figures highlight the critical need for ongoing viral load testing and effective sample collection protocols to support timely diagnosis and treatment.
Key Market Challenges
Quality Control and Standardization Issues
Ensuring consistent quality and standardization in specimen collection across varied environments presents a significant challenge, particularly in low-resource or high-demand outbreak situations. Accurate diagnostic outcomes depend on the integrity of the specimen from collection to analysis, which can be compromised by inconsistent handling procedures, equipment variation, and lack of trained personnel. Although global agencies like WHO and CDC have outlined standard operating procedures, adherence remains uneven—especially in community-level or decentralized settings. For instance, WHO's guidance during the COVID-19 pandemic stressed that improper specimen collection contributed to false-negative results, even in high-income countries. Challenges such as incorrect swab usage or inadequate temperature control during transport can severely impact diagnostic reliability.
Key Market Trends
Automation and Digitalization in Specimen Handling
A key trend reshaping the virology specimen collection market is the adoption of automation and digital tools in specimen management. Automated systems reduce manual errors, maintain sample integrity, and streamline the overall process from collection to analysis. Technologies such as barcoded specimen tubes, automated swab collection, electronic order entry, and laboratory information management systems (LIMS) are enhancing operational efficiency. These innovations ensure chain-of-custody, improve tracking, and minimize contamination risks. During the COVID-19 crisis, digital health platforms enabled home-based sample collection and automatic result reporting to centralized databases, illustrating the scalability and effectiveness of integrated tech-enabled solutions in virology diagnostics.
Key Market Players
• Becton, Dickinson and Company
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC
• Titan Biotech Ltd.
• DiaSorin S.p.A.
• Vircell S.L.
• Copan Italia S.P.A.
• Puritan Medical Products Co.
• Hardy Diagnostics
Report Scope:
In this report, the Global Virology Specimen Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Virology Specimen Collection Market, By Product Type:
o Viral Transport Media
o Specimen Collection Tubes
o Swabs
o Blood Collection Kits
• Virology Specimen Collection Market, By Sample:
o Blood Samples
o Cervical Samples
o Nasal Samples
o Nasopharyngeal Samples
o Throat Samples
o Oral Samples
o Other Samples
• Virology Specimen Collection Market, By Region:
o North America
§ United States
§ Mexico
§ Canada
o Europe
§ France
§ Germany
§ United Kingdom
§ Italy
§ Spain
o Asia-Pacific
§ China
§ India
§ South Korea
§ Japan
§ Australia
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East and Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Virology Specimen Collection Market.
Available Customizations:
Global Virology Specimen Collection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Virology Specimen Collection Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
5.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.4. By Company (2024)
5.3. Market Map
5.3.1 By Product Type
5.3.2 By Sample
5.3.3 By Region
6. North America Virology Specimen Collection Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
6.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Virology Specimen Collection Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Sample
6.3.2. Canada Virology Specimen Collection Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Sample
6.3.3. Mexico Virology Specimen Collection Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Sample
7. Europe Virology Specimen Collection Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
7.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Virology Specimen Collection Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Sample
7.3.2. Germany Virology Specimen Collection Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Sample
7.3.3. United Kingdom Virology Specimen Collection Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Sample
7.3.4. Italy Virology Specimen Collection Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Sample
7.3.5. Spain Virology Specimen Collection Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Sample
8. Asia-Pacific Virology Specimen Collection Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
8.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Virology Specimen Collection Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Sample
8.3.2. India Virology Specimen Collection Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Sample
8.3.3. Japan Virology Specimen Collection Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Sample
8.3.4. South Korea Virology Specimen Collection Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Sample
8.3.5. Australia Virology Specimen Collection Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Sample
9. South America Virology Specimen Collection Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
9.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Virology Specimen Collection Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Sample
9.3.2. Argentina Virology Specimen Collection Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Sample
9.3.3. Colombia Virology Specimen Collection Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Sample
10. Middle East and Africa Virology Specimen Collection Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
10.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Virology Specimen Collection Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Sample
10.3.2. Saudi Arabia Virology Specimen Collection Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Sample
10.3.3. UAE Virology Specimen Collection Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Sample
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Virology Specimen Collection Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Becton, Dickinson and Company
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Quidel Corporation
15.3. Thermo Fisher Scientific Inc.
15.4. Trinity Biotech PLC
15.5. Titan Biotech Ltd.
15.6. DiaSorin S.p.A.
15.7. Vircell S.L.
15.8. Copan Italia S.P.A.
15.9. Puritan Medical Products Co.
15.10. Hardy Diagnostics
16. Strategic Recommendations
17. About Us & Disclaimer